Peptide of the Week: Tirzepatide, a Game Changer for Type 2 Diabetes and Obesity Management Burick Center for Health and Wellness Subcutaneous Injection: What It Is and How to Give One BPC 157 Dosing (Common Protocols), Oral Subcutaneous, 500 mcg daily, Duration: 6 weeks, Intramuscular Peritendinous, 1 mg daily, Duration: 6 weeks, Note:, Not approved by FDA or Oral vs Injectable BPC 157: Differences, Benefits, and When to Use Eac Revolution Health & Wellness Stable Gastric Pentadecapeptide BPC 157 as Therapy After Surgical Detachment of the Quadriceps Muscle from Its Attachments for Muscle to Bone Reattachment in Rats